Source: wikibot/bectumomab
= Bectumomab
{wiki=Bectumomab}
Bectumomab is a monoclonal antibody that was developed for use in the treatment of certain types of cancer, particularly non-Hodgkin lymphoma. It specifically targets the CD19 antigen, which is commonly expressed on the surface of B-cell lymphoid malignancies. By binding to CD19, Bectumomab may help to direct the immune system's response against cancer cells, potentially leading to their destruction.